Decision Modeling Center VUmc

  • Home
  • Expertise
  • Team
  • Publications
  • News
  • Contact

19 Oct 2017

Presenting our work: The EUROGIN 2017 Congress

Last week Venetia Qendri presented her most recent work at the 2017 edition of the EUROGIN congress, which took place in Amsterdam from October 8 to October 11. This work concerns the health impact and cost-effectiveness of sex-neutral vaccination against HPV in Europe.

Research Aim

Most countries in Europe have currently established vaccination of preadolescent girls against HPV, but vaccine uptake in the girls-only programmes varies substantially between countries. Two dose schedules implemented since 2014 in combination with established procurement procedures for the HPV vaccine have reduced the total cost of vaccination in many national immunization programmes. These elements combined deem sex-neutral vaccination against HPV an appealing intervention for the improvement of the programmes. Hence, we expand our previously published framework developed for the Netherlands to evaluate the health impact and cost-effectiveness of sex-neutral vaccination against HPV in other European tender-based settings.

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Google+ (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Filed Under: Conference

  • Email
  • LinkedIn
  • Twitter

© 2022 Decision Modelling Center VUmc · Webdesign: Alva Design

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.